Hamilton Lane Advisors LLC Adaptive Biotechnologies Corp Transaction History

Hamilton Lane Advisors LLC

  • $93.6 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 15, 2020
SELL
$35.79 - $48.81 $696,401 - $949,744
-19,458 Closed
0 $0
Q2 2020

Jul 16, 2020
SELL
$24.95 - $48.38 $804,512 - $1.56 Million
-32,245 Reduced 62.37%
19,458 $941,000
Q1 2020

Apr 27, 2020
BUY
$16.96 - $34.16 $876,882 - $1.77 Million
51,703 New
51,703 $1.44 Million

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $903M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email